Chapter 34: Fertility and Reproduction Drugs

Fertility and Reproduction Drugs provides a comprehensive overview of hormone replacement therapy for menopausal women, examining how estrogen and progestin combinations alleviate symptoms like hot flashes while weighing the risks and benefits regarding cardiovascular health and bone density. The discussion on contraception covers a wide array of methods, including monophasic and multiphasic oral pills, long-acting reversible contraceptives such as intrauterine devices and implants, and emergency postcoital options, explaining their synergistic mechanisms of suppressing ovulation and altering cervical mucus. The chapter also highlights selective estrogen receptor modulators like clomiphene for treating infertility and raloxifene for osteoporosis, as well as the use of aromatase inhibitors and selective estrogen receptor degraders in managing breast cancer. Additionally, the text covers the therapeutic use of androgens for hypogonadism and the role of antiandrogens and reductase inhibitors in treating conditions like prostate cancer and benign prostatic hyperplasia. In the field of obstetrics, it details the management of pregnancy-induced hypertension, the use of tocolytics to delay preterm labor, and the induction of labor through agents like oxytocin and prostaglandins. Finally, it addresses newer treatments for female sexual dysfunction and the rapid-acting intervention for postpartum depression, brexanolone, ensuring a thorough understanding of reproductive pharmacology for clinical and academic purposes.